- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology and Emerging Companies
- Government Matters
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries
- Careers
- News & Insights
- About
- Languages
Evan Diamond
News 8 results
In the News · Source: Law360
October 8, 2019
Gerald Flattmann Jr., Evan Diamond and Vanessa Yen secure a victory for Galderma in its patent infringement dispute against Sun Pharmaceutical
Cases & Deals
October 4, 2019
Galderma Laboratories wins a major patent infringment case in Delaware
Recognition
September 19, 2019
LMG Life Sciences Recognizes King & Spalding With Hatch-Waxman Impact Case of the Year Award
In the News · Source: The Center for Biosimilars
June 25, 2019
Evan Diamond discusses the impact of reimbursement policies in the biosimilar market at the ACI 10th Summit on Biosimilars
Events 3 results
Speaking Engagement
June 24, 2019
Evan Diamond, Vanessa Yen to Speak at ACI’s 2019 Summit on Biosimilars
Conference
June 20, 2019
5th Annual West Coast Pharmaceutical & Medical Device University
Insights 5 results
Article · Source: Law360
August 20, 2019
Fed. Circ.'s Arduous Legal Landscape For Diagnostic Patents
Client Alert
August 13, 2019
Federal Circuit Continues Trend of Finding Diagnostic Inventions to Be Patent-Ineligible
Article · Source: Bloomberg Law
April 29, 2019
Big Pharma Should Watch SCOTUS After Circuit Court Finds New Drug Uses Patentable
Article · Source: Law360
January 17, 2019
Takeaways From Fed. Circ. Hatch-Waxman IPR Case